Duesseldorf, Germany

Pascal Ellerbrock

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Location History:

  • Düsseldorf, DE (2019)
  • Duesseldorf, DE (2021)

Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Pascal Ellerbrock: Innovating Medicines for Cardiovascular Health

Introduction:

Pascal Ellerbrock, a talented inventor based in Duesseldorf, DE, has made significant contributions to the field of pharmaceuticals with his groundbreaking innovations. With a total of 2 patents to his name, Ellerbrock is known for his expertise in developing novel medicaments for the treatment and prevention of various diseases, particularly focusing on cardiovascular disorders.

Latest Patents:

One of Ellerbrock's latest patents involves "Substituted oxopyridine derivatives," a groundbreaking invention that showcases his commitment to advancing the field of medicine. These derivatives are specifically designed for the treatment and prophylaxis of cardiovascular disorders, thrombotic or thromboembolic disorders, oedemas, and ophthalmic disorders. This innovative approach highlights Ellerbrock's dedication to improving patient outcomes and addressing critical health challenges.

Career Highlights:

Ellerbrock is a valued member of Bayer Pharma Aktiengesellschaft, a renowned pharmaceutical company known for its commitment to innovation and excellence in healthcare. His role within the company allows him to further explore his passion for creating impactful medicaments that can positively impact the lives of patients worldwide.

Collaborations:

In his professional journey, Ellerbrock has collaborated with esteemed colleagues such as Eloisa Jimenez Nunez and Jens Ackerstaff. These collaborations have not only enhanced his innovative process but have also fostered a creative and dynamic environment where ideas flourish, leading to groundbreaking inventions in the pharmaceutical industry.

Conclusion:

Pascal Ellerbrock's dedication to innovation in pharmaceuticals, particularly in the development of medicaments for cardiovascular health, underscores his commitment to improving global healthcare standards. His inventive spirit and collaborative efforts continue to shape the future of medicine, leaving a lasting impact on the well-being of individuals worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…